<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480478</url>
  </required_header>
  <id_info>
    <org_study_id>518</org_study_id>
    <nct_id>NCT02480478</nct_id>
  </id_info>
  <brief_title>Serum Autotaxin Levels in Cholestasis of Pregnancy</brief_title>
  <official_title>Diagnostic Accuracy of Serum Autotaxin Levels in Cholestasis of Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Hamidiye Etfal Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Hamidiye Etfal Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrahepatic cholestasis of pregnancy is the most common liver disease in pregnancy. It is is
      a pregnancy-specific liver disorder with onset mainly in the third trimester of pregnancy.
      ICP is characterized by pruritus, elevated serum fasting bile salts and transaminases and an
      increased risk of adverse fetal outcomes. Serum autotaxin levels were found highly sensitive
      and specific biomarker to to differentiate ICP from other pregnancy-related liver disorders
      or pruritic dermatoses. The purpose of the study is to determine the diagnostic accuracy of
      serum autotaxin activity in cholestasis of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Collected data will enable us to compare serum autotaxin levels in cholestasis of pregnancy
      and healthy control group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum autotaxin levels in cholestasis of pregnancy</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Intrahepatic Cholestasis of Pregnancy</condition>
  <arm_group>
    <arm_group_label>intrahepatic cholestasis of pregnancy</arm_group_label>
    <description>5 ml whole blood sample is going to collect from intrahepatic cholestasis of pregnancy group for the assessment of serum autotaxin levels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy control group</arm_group_label>
    <description>5 ml of whole blood is going to taken from healthy control group</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      5ml whole blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients who are admitted to obstetrics and gynecology department due to cholestasis of
        pregnancy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosed cholestasis of pregnancy patients

        Exclusion Criteria:

          -  acute or chronic liver disease

          -  acute or chronic gallbladder disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hakan Erenel, MD,OBGYN</last_name>
    <role>Study Director</role>
    <affiliation>Sisli Etfal Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hakan Erenel, MD,OBGYN</last_name>
    <phone>00905063092995</phone>
    <email>hakanerenel@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sisli Etfal Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34371</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakan Erenel, MD, OB/GYN</last_name>
      <phone>00905063092995</phone>
      <email>hakanerenel@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>April 19, 2016</last_update_submitted>
  <last_update_submitted_qc>April 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Hamidiye Etfal Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Hakan Erenel</investigator_full_name>
    <investigator_title>MD, OB/GYN</investigator_title>
  </responsible_party>
  <keyword>Intrahepatic Cholestasis of Pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Cholestasis, Intrahepatic</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

